| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 85 | 190 | 190 | $100 | $122.8K |
| 97597 | The provider excises devitalized (dead) tissue from an open wound, choosing from a variety of techniques; treatment may include topical application of medicine or materials, wound assessment,… | 3 | 10 | 40 | $60 | $67K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7 | 10 | 70 | $20 | $30.1K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 76 | 90 | 140 | $60 | $22.1K |
| 0002A | N/A | 27 | 70 | 160 | $40 | $20.8K |
| 99202 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves straightforward medical decision making, and/or the provider… | 35 | 70 | 80 | $60 | $20.6K |
| 0001A | N/A | 24 | 80 | 140 | $30 | $18.4K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 153 | 230 | 140 | $20 | $16.1K |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 3 | 90 | 180 | $10 | $14.5K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 2 | 40 | 170 | $20 | $13K |